US Broker Ratings

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 48% Potential Upside for Investors

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is gaining attention among investors due to its promising potential upside of 48.09%. Specializing..

Merit Medical Systems, Inc. (MMSI): Investor Outlook with 18% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. Headquartered in South Jordan, Utah,..

Biogen Inc. (BIIB) Stock Analysis: Unpacking the 35% Potential Upside for Investors

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, is a leading player in the drug manufacturing industry. With a robust portfolio focusing on therapies..

HCA Healthcare, Inc. (HCA) Stock Analysis: Evaluating Growth Potential with a 2.71% Upside

HCA Healthcare, Inc. (HCA) has long been a prominent name in the healthcare sector, specifically within the medical care facilities industry. With a significant market capitalization..

Koninklijke Philips N.V. (PHG) Stock Analysis: Potential 42.52% Upside Amidst Challenging Market Dynamics

As a titan in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG), based in the Netherlands, stands at the crossroads of innovation and market challenges. With..

Viatris Inc. (VTRS) Stock Analysis: Unpacking the 28.38% Potential Upside

Viatris Inc. (VTRS), a major player in the healthcare sector, stands at a pivotal juncture that warrants investor attention. With a market capitalization of $10.41 billion,..

Alkermes plc (ALKS) Stock Analysis: Evaluating a 41% Potential Upside in the Biopharmaceutical Sphere

Alkermes plc (NASDAQ: ALKS), a prominent player in the biopharmaceutical industry, has garnered significant attention with a potential upside of 41.17%, as projected by analysts. Headquartered..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 31% Upside Potential in the Healthcare Sector

Revvity, Inc. (RVTY) has emerged as a noteworthy player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $11.2..

Medtronic plc (MDT) Stock Analysis: Exploring a Potential 11.30% Upside with a Strong Dividend Yield

Medtronic plc (MDT), a titan in the healthcare sector, is a company that continues to capture the attention of investors worldwide. Headquartered in Galway, Ireland, Medtronic..

Abbott Laboratories (ABT) Stock Analysis: Navigating a 6.12% Upside Amidst Robust Healthcare Innovations

Abbott Laboratories (NYSE: ABT), a titan in the healthcare sector with a market cap of $231.38 billion, continues to be a focal point for investors seeking..

Regencell Bioscience Holdings (RGC) Stock Analysis: Unveiling the Volatility and Future Prospects in TCM

Regencell Bioscience Holdings Limited, trading under the ticker RGC, is a dynamic player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry...

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech Gem with a Promising 66% Upside Potential

Investors seeking opportunities in the biotechnology sector may find ADMA Biologics Inc (NASDAQ: ADMA) an intriguing prospect. With a market capitalization of $4.24 billion, this U.S.-based..

Exact Sciences Corporation (EXAS) Stock Analysis: 29.87% Potential Upside Amid Strong Buy Ratings

Exact Sciences Corporation (NASDAQ: EXAS) represents a compelling opportunity for investors interested in the healthcare sector, particularly in diagnostics and research. With a market capitalization of..

The Ensign Group, Inc. (ENSG) Stock Analysis: Uncovering a 7.57% Upside Potential in Healthcare

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring Potential Upside and Analyst Ratings

Intuitive Surgical, Inc. (NASDAQ: ISRG), a trailblazer in the healthcare sector, is setting the stage for a transformative future in minimally invasive medical procedures. With a..

Edwards Lifesciences (EW) Stock Analysis: Unveiling a 9.72% Potential Upside for Investors

Edwards Lifesciences Corporation (NYSE: EW), a leading player in the medical devices industry, primarily focuses on advanced cardiovascular disease solutions. With a substantial market cap of..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating Growth in Biotechnology with a 1.87% Potential Upside

Blueprint Medicines Corporation (NASDAQ: BPMC) is making significant strides in the biotechnology sector, driven by its focus on developing precision therapies for genomically defined cancers and..

Teva Pharmaceutical Industries (TEVA) Investor Outlook: Analyst Ratings Signal 39% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the global healthcare sector, continues to capture investor attention with its diverse portfolio of generic and specialty medicines...

Corcept Therapeutics (CORT) Stock Analysis: A Robust Biotech Player with Nearly 94% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) is capturing investor attention in the healthcare sector, particularly within biotechnology, thanks to its promising drug development pipeline and substantial potential..

Charles River Laboratories (CRL) Stock Analysis: Navigating Challenges with Strategic Initiatives

Charles River Laboratories International, Inc. (NYSE: CRL) is a key player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds